You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The Washington Post discusses how graduate students in the US are affected by the SARS-CoV-2 pandemic and the reopening of universities.
In PLOS this week: computational tool to uncover selection within populations, sequencing-based analysis of canine lymphoma, and more.
According to Retraction Watch, Ohio State University's Carlo Croce is being sued by his former lawyers for payment.
The tests are designed to detect regions in the SARS-CoV-2 genome in respiratory samples or antibodies against the virus in human serum, plasma, or blood.
New Scientist describes next steps supporters of the #ShutdownSTEM strike could take to combat racism in academia.
Investigators are building upon an initial case study that allowed them to assess how well ctDNA captured a cancer's full genomic heterogeneity compared to tissue biopsies.
According to Retraction Watch, a US federal judge has ruled against Ohio State University professor Carlo Croce in a defamation case he brought.
A recent study has found jargon in scientific writing can turn readers off, Nature Careers reports.
All three methods build on the use of methyltransferases to mark accessible regions of the genome, using nanopore sequencing to detect the modifications.
An analysis of Tibetan ice cores uncovers more than two dozen previously unknown virus groups, LiveScience reports.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.